Literature DB >> 11349061

Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucans.

P Kougias1, D Wei, P J Rice, H E Ensley, J Kalbfleisch, D L Williams, I W Browder.   

Abstract

Fungal cell wall glucans nonspecifically stimulate various aspects of innate immunity. Glucans are thought to mediate their effects via interaction with membrane receptors on macrophages, neutrophils, and NK cells. There have been no reports of glucan receptors on nonimmune cells. We investigated the binding of a water-soluble glucan in primary cultures of normal human dermal fibroblasts (NHDF). Membranes from NHDF exhibited saturable binding with an apparent dissociation constant (K(D)) of 8.9 +/- 1.9 microg of protein per ml and a maximum binding of 100 +/- 8 resonance units. Competition studies demonstrated the presence of at least two glucan binding sites on NHDF. Glucan phosphate competed for all binding sites, with a K(D) of 5.6 microM (95% confidence interval [CI], 3.0 to 11 microM), while laminarin competed for 69% +/- 6% of binding sites, with a K(D) of 3.7 microM (95% CI, 1.9 to 7.3 microM). Glucan (1 microg/ml) stimulated fibroblast NF-kappaB nuclear binding activity and interleukin 6 (IL-6) gene expression in a time-dependent manner. NF-kappaB was activated at 4, 8, and 12 h, while IL-6 mRNA levels were increased by 48% at 8 h. This is the first report of pattern recognition receptors for glucan on human fibroblasts and the first demonstration of glucan binding sites on cells other than leukocytes. It also provides the first evidence that glucans can directly modulate the functional activity of NHDF. These results provide new insights into the mechanisms by which the host recognizes and responds to fungal (1-->3)-beta-D-glucans and suggests that the response to glucans may not be confined to cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349061      PMCID: PMC98428          DOI: 10.1128/IAI.69.6.3933-3938.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Authors:  V Vetvicka; B P Thornton; G D Ross
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  A lipopolysaccharide- and beta-1,3-glucan-binding protein from hemocytes of the freshwater crayfish Pacifastacus leniusculus. Purification, characterization, and cDNA cloning.

Authors:  S Y Lee; R Wang; K Söderhäll
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

4.  Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).

Authors:  V Vetvicka; B P Thornton; T J Wieman; G D Ross
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

5.  Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts.

Authors:  P L Wang; Y Azuma; M Shinohara; K Ohura
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

6.  Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.

Authors:  E A van Tol; L Holt; F L Li; F M Kong; R Rippe; M Yamauchi; J Pucilowska; P K Lund; R B Sartor
Journal:  Am J Physiol       Date:  1999-07

7.  A pattern-recognition protein for beta-1,3-glucan. The binding domain and the cDNA cloning of beta-1,3-glucan recognition protein from the silkworm, Bombyx mori.

Authors:  M Ochiai; M Ashida
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

8.  Inhibition of LPS-induced NFkappaB activation by a glucan ligand involves down-regulation of IKKbeta kinase activity and altered phosphorylation and degradation of IkappaBalpha.

Authors:  D L Williams; T Ha; C Li; J Laffan; J Kalbfleisch; W Browder
Journal:  Shock       Date:  2000-06       Impact factor: 3.454

9.  A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes.

Authors:  J W Zimmerman; J Lindermuth; P A Fish; G P Palace; T T Stevenson; D E DeMong
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

10.  Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae.

Authors:  D L Williams; H A Pretus; R B McNamee; E L Jones; H E Ensley; I W Browder; N R Di Luzio
Journal:  Immunopharmacology       Date:  1991 Nov-Dec
View more
  12 in total

1.  Induction of immunoglobulin G1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates.

Authors:  Senarath Dissanayake; Nasir Khan; Allen Shahin; Shanaka Wijesinghe; Miodrag Lukic
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Evaluation of electrospun (1,3)-(1,6)-β-D-glucans/biodegradable polymer as artificial skin for full-thickness wound healing.

Authors:  Hye-Lee Kim; Jeong-Hyun Lee; Mi Hee Lee; Byeong Ju Kwon; Jong-Chul Park
Journal:  Tissue Eng Part A       Date:  2012-08-08       Impact factor: 3.845

3.  Lectin site ligation of CR3 induces conformational changes and signaling.

Authors:  Xian M O'Brien; Katie E Heflin; Liz M Lavigne; Kebing Yu; Minsoo Kim; Arthur R Salomon; Jonathan S Reichner
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

4.  Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation.

Authors:  Elio Cenci; Antonella Mencacci; Antonio Spreca; Claudia Montagnoli; Angela Bacci; Katia Perruccio; Andrea Velardi; Walter Magliani; Stefania Conti; Luciano Polonelli; Luigina Romani
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Cellular and molecular mechanisms of fungal β-(1→6)-glucan in macrophages.

Authors:  Ilka Noss; Tammy R Ozment; Bridget M Graves; Michael D Kruppa; Peter J Rice; David L Williams
Journal:  Innate Immun       Date:  2015-07-23       Impact factor: 2.680

Review 6.  Antiinflammatory and immunomodulating properties of fungal metabolites.

Authors:  Cristina Lull; Harry J Wichers; Huub F J Savelkoul
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

7.  The Effect of Mushroom Beta-Glucans from Solid Culture of Ganoderma lucidum on Inhibition of the Primary Tumor Metastasis.

Authors:  Shiu-Nan Chen; Ching-Sheng Chang; Ming-Hsin Hung; Sherwin Chen; William Wang; Cheng-Jeng Tai; Chung-Lun Lu
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-01       Impact factor: 2.629

8.  Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Authors:  Juergen Luhm; Ulrich Langenkamp; Jenny Hensel; Christoph Frohn; Joerg M Brand; Holger Hennig; Lothar Rink; Petra Koritke; Nadine Wittkopf; David L Williams; Antje Mueller
Journal:  BMC Immunol       Date:  2006-03-22       Impact factor: 3.615

Review 9.  Immunostimulatory properties and antitumor activities of glucans (Review).

Authors:  Luca Vannucci; Jiri Krizan; Petr Sima; Dmitry Stakheev; Fabian Caja; Lenka Rajsiglova; Vratislav Horak; Mustafa Saieh
Journal:  Int J Oncol       Date:  2013-06-05       Impact factor: 5.650

10.  β-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.

Authors:  Shawn M Talbott; Julie A Talbott; Tracy L Talbott; Elaine Dingler
Journal:  Food Sci Nutr       Date:  2014-01-08       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.